Canaccord Genuity Inc. and Barclays Capital Inc. are acting as the joint bookrunning managers for the offering. Raymond James & Associates, Inc. and SG Americas Securities, LLC are acting as co-managers.
Net proceeds, after underwriting discounts and commissions and other estimated fees and expenses payable by BioAmber will be approximately $32.8 million.
Read the Full Press Release Here
BioAmber Inc. Announces Pricing Of $35.1 Million Registered Offering
BioAmber today announced that it has priced an underwritten registered offering of 3,900,000 shares of its common stock at a price of $9.00 per share
May 1, 2015
BioAmber also granted the underwriters in the offering a 30-day option to purchase up to an additional 585,000 shares of its common stock. The gross proceeds to the Company will be $35.1 million. The offering is expected to close on May 6, 2015, subject to customary closing conditions.